Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly
Clinical trial NCT02729168 · COMPLETED
Trial details
- NCT number
- NCT02729168
- Sponsor
- Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2015-10-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.